Australian biotech market today 28.04.09
Tuesday, 28 April, 2009
The healthcare indices are up a very healthy 2.6 per cent on the market at 3.00pm on a day when other shares lost yesterday’s gains.
Biota (ASX:BTA) is down a touch following its massive rise yesterday, when shares shot up 80 per cent. It has settled at a very respectable $1.50 today.
Investors obviously like the look of any stocks with a whiff of swine flu, as vaccine developer CSL (ASX:CLS) is up $1.15 to $33.
In terms of the other majors, Cochlear (ASX:COH) is up $1 while ResMed (ASX:RMD) is up 3c.
Hexima (ASX:HXL) is up 3c to 45c – see our profile of the agbiotech company, published today.
Alchemia (ASX:ACL) is almost 19 per cent, while Mesoblast (ASX:MSB) is down 4c to 73c.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
